DCZ0415 is primarily used in research settings to study its effects on cellular processes, particularly in the context of cancer. It functions as a selective inhibitor of certain kinases, which are enzymes that play a critical role in cell signaling and regulation. By targeting these kinases, DCZ0415 has shown potential in disrupting the growth and survival of cancer cells, making it a candidate for further investigation in oncology. Researchers are exploring its efficacy in preclinical models to understand its mechanism of action and potential therapeutic applications, especially in treating hematological malignancies and solid tumors. Additionally, it is used as a tool compound to better understand kinase signaling pathways and their role in disease progression.